- Home
- SGLY vs IMCC Comparison
SGLY vs IMCC Comparison
Compare SGLY & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGLY | IMCC |
|---|---|---|
| Founded | 2001 | 1980 |
| Country | United States | Israel |
| Employees | N/A | 55 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 3.0M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SGLY | IMCC |
|---|---|---|
| Price | $0.39 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.7K | ★ 95.9K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,813,193.00 | N/A |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.34 | $0.47 |
| 52 Week High | $1.46 | $7.12 |
Technical Indicators
Market Signals| Indicator | SGLY | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 28.77 |
| Support Level | $0.38 | N/A |
| Resistance Level | $0.43 | $1.55 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 34.78 | 5.17 |
Price Performance
Historical ComparisonAbout SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.